Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CODX Co Diagnostics Inc

-0.06 (-5.26%)
May 17 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 58,800
Bid Price 1.09
Ask Price 1.24
News -
Day High 1.17


52 Week Range


Day Low 1.10
Company Name Stock Ticker Symbol Market Type
Co Diagnostics Inc CODX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -5.26% 1.08 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.15 1.10 1.17 1.09 1.14
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
352 58,800 $ 1.14 $ 67,033 - 0.975 - 1.89
Last Trade Time Type Quantity Stock Price Currency
16:56:21 formt 308 $ 1.08 USD

Co Diagnostics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
34.39M 31.26M - 6.81M -36.41M -1.16 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Co Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CODX Message Board. Create One! See More Posts on CODX Message Board See More Message Board Posts

Historical CODX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.,990-0.09-7.69%
1 Month1.141.301.031.1646,496-0.06-5.26%
3 Months1.131.301.021.1558,609-0.05-4.42%
6 Months1.421.65671.021.2581,756-0.34-23.94%
1 Year1.381.890.9751.2689,930-0.30-21.74%
3 Years8.4011.820.9756.99371,937-7.32-87.14%
5 Years0.932131.400.69411.141,608,6590.147915.87%

Co Diagnostics Description

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Your Recent History

Delayed Upgrade Clock